Society guideline links: Chemotherapy-induced nausea and vomiting in adults

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Nausea and vomiting".)

International

●Multinational Association of Supportive Care in Cancer (MASCC) and European Society for Medical Oncology (ESMO): Guideline for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting, 2023 update (published 2024)

●MASCC/ESMO: Antiemetic guidelines, update (2023)

Canada

●Cancer Care Ontario (CCO): Antiemetic recommendations for chemotherapy-induced nausea and vomiting – A clinical practice guideline (2019)

United States

●National Cancer Institute (NCI): Treatment-related nausea and vomiting – Health professional version

●American Society of Clinical Oncology (ASCO): Guideline on antiemetics, update (2020)

●Oncology Nursing Society (ONS): Antiemetic guidelines – Using education to improve adherence and reduce incidence of CINV in patients receiving highly emetogenic chemotherapy (2018)

Europe

●Multinational Association of Supportive Care in Cancer (MASCC) and European Society for Medical Oncology (ESMO): Guideline for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting, 2023 update (published 2024)

●MASCC/ESMO: Antiemetic guidelines, update (2023)

Japan

●[In Japanese] Japanese Society of Clinical Oncology (JSCO): Guidelines for the proper use of antiemetics 2015, update (2018)